CO-DIAGNOSTICS INC (CODX) Stock Price & Overview
NASDAQ:CODX • US1897632048
Current stock price
The current stock price of CODX is 2.59 USD. Today CODX is down by -2.26%. In the past month the price decreased by -64.15%. In the past year, price decreased by -89.26%.
CODX Key Statistics
- Market Cap
- 5.258M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -29.70
- Dividend Yield
- N/A
CODX Stock Performance
CODX Stock Chart
CODX Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to CODX. When comparing the yearly performance of all stocks, CODX is a bad performer in the overall market: 99.03% of all stocks are doing better.
CODX Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to CODX. The financial health of CODX is average, but there are quite some concerns on its profitability.
CODX Earnings
On March 19, 2026 CODX reported an EPS of -4.8 and a revenue of 145.00K. The company beat EPS expectations (1.96% surprise) and missed revenue expectations (-5.23% surprise).
CODX Forecast & Estimates
7 analysts have analysed CODX and the average price target is 30.6 USD. This implies a price increase of 1081.47% is expected in the next year compared to the current price of 2.59.
For the next year, analysts expect an EPS growth of 36.81% and a revenue growth -88.3% for CODX
CODX Groups
Sector & Classification
CODX Financial Highlights
Over the last trailing twelve months CODX reported a non-GAAP Earnings per Share(EPS) of -29.7. The EPS increased by 22.05% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -71.93% | ||
| ROE | -80.8% | ||
| Debt/Equity | 0 |
CODX Ownership
CODX Latest News, Press Relases and Analysis
CODX Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 18.36 | 183.255B | ||
| ISRG | INTUITIVE SURGICAL INC | 46.76 | 169.761B | ||
| SYK | STRYKER CORP | 22.19 | 128.458B | ||
| BSX | BOSTON SCIENTIFIC CORP | 19.87 | 103.101B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.38 | 47.916B | ||
| IDXX | IDEXX LABORATORIES INC | 38.94 | 45.961B | ||
| BDX | BECTON DICKINSON AND CO | 11.31 | 43.887B | ||
| RMD | RESMED INC | 18.4 | 32.922B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 13.48 | 31.743B | ||
| DXCM | DEXCOM INC | 26.33 | 25.766B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.36 | 17.192B | ||
| HOLX | HOLOGIC INC | 15.36 | 16.835B | ||
| PODD | INSULET CORP | 35.13 | 15.988B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About CODX
Company Profile
Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. The company is headquartered in Salt Lake City, Utah and currently employs 132 full-time employees. The company went IPO on 2017-07-12. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The firm also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. The company is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.
Company Info
IPO: 2017-07-12
CO-DIAGNOSTICS INC
2401 S. Foothill Dr. Suite D
Salt Lake City UTAH 84109 US
CEO: Dwight Egan
Employees: 132
Phone: 18014381036
CO-DIAGNOSTICS INC / CODX FAQ
What does CO-DIAGNOSTICS INC do?
Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. The company is headquartered in Salt Lake City, Utah and currently employs 132 full-time employees. The company went IPO on 2017-07-12. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The firm also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. The company is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.
What is the stock price of CO-DIAGNOSTICS INC today?
The current stock price of CODX is 2.59 USD. The price decreased by -2.26% in the last trading session.
Does CODX stock pay dividends?
CODX does not pay a dividend.
What is the ChartMill technical and fundamental rating of CODX stock?
CODX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is the market capitalization of CODX stock?
CO-DIAGNOSTICS INC (CODX) has a market capitalization of 5.26M USD. This makes CODX a Nano Cap stock.
What is the next earnings date for CODX stock?
CO-DIAGNOSTICS INC (CODX) will report earnings on 2026-05-06.
Can you provide the short interest for CODX stock?
The outstanding short interest for CO-DIAGNOSTICS INC (CODX) is 0.01% of its float.